Apogee Therapeutics (APGE) Retained Earnings (2022 - 2026)

Apogee Therapeutics (APGE) has 5 years of Retained Earnings data on file, last reported at -$749000.0 in Q1 2026.

• On a quarterly basis, Retained Earnings rose 99.79% year-over-year to -$749000.0 in Q1 2026; TTM through Mar 2026 was -$749000.0, a 99.79% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, down 99.89% from the prior year.
• Retained Earnings for Q1 2026 stood at -$749000.0, down from $1.1 million in the prior quarter.
• Over the last five years, Retained Earnings for APGE reached as high as $1.1 billion in Q3 2025 and fell as low as -$427.4 million in Q2 2025.
• Historically, Retained Earnings has averaged $66.9 million across 5 years, with a median of -$749000.0 in 2026.
• Across the five-year window, Retained Earnings soared 310475.68% in 2024 and slumped 203998.87% in 2025, its largest moves.
• Year by year, Retained Earnings stood at -$39.8 million in 2022, then surged by 100.83% to $329000.0 in 2023, then surged by 310475.68% to $1.0 billion in 2024, then sank by 99.89% to $1.1 million in 2025, then plunged by 169.35% to -$749000.0 in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were -$749000.0 in Q1 2026, $1.1 million in Q4 2025, and $1.1 billion in Q3 2025.